V1 sact_drug_detail
6,385,827 rows · 11 columns
| MERGED_DRUG_DETAIL_ID | MERGED_CYCLE_ID | ORG_CODE_OF_DRUG_PROVIDER | ACTUAL_DOSE_PER_ADMINISTRATION | OPCS_DELIVERY_CODE | ADMINISTRATION_ROUTE | ADMINISTRATION_DATE | DRUG_GROUP | MERGED_PATIENT_ID | MERGED_TUMOUR_ID | MERGED_REGIMEN_ID |
|---|---|---|---|---|---|---|---|---|---|---|
| 16688915 | 330036234 | ED617 | 460 | X724 | 1 | 2015-12-18 | CETUXIMAB | 330003558 | 330003497 | 330006741 |
| 16688916 | 330036234 | Haqrsvarq | 480 | X724 | 1 | 2015-12-18 | ETOPOSIDE | 330003558 | 330003497 | 330006741 |
| 16688917 | 330036234 | EK1PP | 585 | X729 | 1 | 2015-12-19 | IFOSFAMIDE | 330003558 | 330003497 | 330006741 |
| 16688918 | 330036234 | EC5 | 12.5 | null | 1 | 2015-12-19 | BRENTUXIMAB VEDOTIN | 330003558 | 330003497 | 330006741 |
| 16688919 | 330036234 | EUDJC | 86 | X724 | 5 | 2015-12-20 | VINCRISTINE | 330003558 | 330003497 | 330006741 |
| 16688920 | 330036235 | EUDUU | 6300 | X723 | 1 | 2016-05-13 | BUSULFAN | 330005089 | 330003562 | 330006811 |
| 16688921 | 330036235 | ED617 | null | X724 | 1 | 2016-05-13 | NOT CHEMO | 330005089 | 330003562 | 330006811 |
| 16688922 | 330036235 | EJR | 190 | X721 | 1 | 2016-05-13 | PERTUZUMAB | 330005089 | 330003562 | 330006811 |
| 16688923 | 330036236 | EJR | 100 | null | 1 | 2016-02-01 | RITUXIMAB | 330005358 | 330003614 | 330006858 |
| 16688924 | 330036238 | EJRNN | 555 | X723 | 1 | 2018-01-15 | BUSULFAN | 330007427 | 330003810 | 330007025 |
| 16688925 | 330036241 | EEI00 | 370 | X731 | 1 | 2014-06-25 | OFATUMUMAB | 330012718 | 330004624 | 330007797 |
| 16688926 | 330036242 | EWR01 | 200 | null | 2 | 2016-04-23 | BORTEZOMIB | 330012903 | 330004661 | 330007845 |
| 16688927 | 330036242 | EJR | 21.75 | X729 | 1 | 2016-04-30 | DOCETAXEL | 330012903 | 330004661 | 330007845 |
| 16688928 | 330036242 | ETG | 21.75 | X724 | 1 | 2016-04-30 | BLEOMYCIN | 330012903 | 330004661 | 330007845 |
| 16688929 | 330036244 | Haqrsvarq | 100 | X731 | 2 | 2015-04-03 | GEMCITABINE | 330000242 | 330002982 | 330009378 |
| 16688930 | 330036244 | EK1PP | 140 | null | 1 | 2015-04-03 | IFOSFAMIDE | 330000242 | 330002982 | 330009378 |
| 16688931 | 330036244 | Haqrsvarq | 0 | X731 | 5 | 2015-04-10 | RITUXIMAB | 330000242 | 330002982 | 330009378 |
| 16688932 | 330036244 | EJR | 360 | X724 | 1 | 2015-04-17 | CYCLOPHOSPHAMIDE | 330000242 | 330002982 | 330009378 |
| 16688933 | 330036245 | EEI00 | 245 | null | 1 | 2014-11-18 | CYTARABINE | 330002811 | 330003346 | 330009558 |
| 16688934 | 330036246 | ES4DU | 200 | X723 | null | null | VINBLASTINE | 330003329 | 330003441 | 330009612 |
| 16688935 | 330036246 | EUDUU | 10 | X722 | 1 | null | STEROID | 330003329 | 330003441 | 330009612 |
| 16688936 | 330036247 | EEI00 | 0 | X724 | 1 | 2017-03-05 | FLUOROURACIL | 330003375 | 330003457 | 330009620 |
| 16688937 | 330036247 | EZ1 | 370 | X721 | 5 | 2017-03-06 | PERTUZUMAB | 330003375 | 330003457 | 330009620 |
| 16688938 | 330036247 | EEI00 | 0 | X729 | 1 | 2017-03-06 | ETOPOSIDE | 330003375 | 330003457 | 330009620 |
| 16688939 | 330036248 | EDZ01 | 65 | X731 | 2 | 2019-08-01 | SORAFENIB | 330005520 | 330003635 | 330009707 |
| 16688940 | 330036248 | Haqrsvarq | 191 | X724 | 2 | 2019-08-01 | GEMCITABINE | 330005520 | 330003635 | 330009707 |
| 16688941 | 330036249 | EGT | 360 | X729 | 1 | 2015-10-03 | BUSULFAN | 330008208 | 330004008 | 330009912 |
| 16688942 | 330036250 | EJR | 4080 | X724 | 1 | 2017-03-05 | DOCETAXEL | 330010968 | 330004285 | 330010060 |
| 16688943 | 330036251 | ERA20 | 98 | X721 | 1 | 2015-10-16 | CAPECITABINE | 330012360 | 330008470 | 330010196 |
| 16688944 | 330036252 | EUZ | 400 | X722 | 2 | 2018-01-10 | NOT CHEMO | 330013738 | 330011814 | 330010343 |
| 16688945 | 330036256 | EW100 | 2 | null | 1 | null | IPILIMUMAB | 330002306 | 330005998 | 330010999 |
| 16688946 | 330036256 | EK1PP | 132 | X721 | 1 | null | CYTARABINE | 330002306 | 330005998 | 330010999 |
| 16688947 | 330036258 | ECL02 | null | X723 | 1 | 2017-03-12 | CETUXIMAB | 330020977 | 330010881 | 330012832 |
| 16688948 | 330036259 | EKU01 | 10 | null | 1 | 2015-03-15 | BORTEZOMIB | 330014135 | 330004839 | 330013017 |
| 16688949 | 330036261 | ELW | 190 | null | 1 | 2016-08-02 | THALIDOMIDE | 330008719 | 330001317 | 330002342 |
| 16688950 | 330036261 | EEI00 | 300 | null | 2 | 2016-08-02 | NOT CHEMO | 330008719 | 330001317 | 330002342 |
| 16688951 | 330036261 | EK1PP | 140 | null | 1 | 2016-08-03 | GEMCITABINE | 330008719 | 330001317 | 330002342 |
| 16688952 | 330036261 | EJU04 | 140 | X729 | 1 | 2016-08-09 | TRASTUZUMAB | 330008719 | 330001317 | 330002342 |
| 16688953 | 330036262 | ELW | 1500 | X724 | 2 | 2015-06-30 | VINORELBINE | 330014753 | 330012668 | 330003885 |
| 16688954 | 330036263 | ES4DU | 4080 | X724 | 1 | 2018-04-02 | GEMCITABINE | 330014960 | 330007069 | 330003932 |
| 16688955 | 330036265 | EGSSF | 8 | X729 | 1 | 2018-01-10 | IBRUTINIB | 330021700 | 330007358 | 330005148 |
| 16688956 | 330036269 | EGU08 | 10 | X724 | 1 | null | NOT CHEMO | 330023851 | 330007443 | 330005524 |
| 16688957 | 330036269 | EK1PP | 100 | X731 | 1 | null | CISPLATIN | 330023851 | 330007443 | 330005524 |
| 16688958 | 330036269 | EJR | 12.5 | X724 | 2 | null | STEROID | 330023851 | 330007443 | 330005524 |
| 16688959 | 330036270 | EK1PP | 12.5 | null | 1 | 2016-07-15 | NOT CHEMO | 330023962 | 330002651 | 330005546 |
| 16688960 | 330036270 | EJR | 140 | X723 | 2 | 2016-07-22 | DOCETAXEL | 330023962 | 330002651 | 330005546 |
| 16688961 | 330036271 | EK1PP | 4080 | null | 2 | null | IFOSFAMIDE | 330024392 | 330002691 | 330005657 |
| 16688962 | 330036272 | EWR01 | 4500 | X729 | 2 | 2015-07-20 | NOT CHEMO | 330024440 | 330002697 | 330005672 |
| 16688963 | 330036272 | EZP01 | null | null | 1 | 2015-07-30 | FLUDARABINE | 330024440 | 330002697 | 330005672 |
| 16688964 | 330036272 | ED617 | 500 | N/A | 1 | 2015-07-31 | CETUXIMAB | 330024440 | 330002697 | 330005672 |